Please assess the completion status of the following clinical trial:

Trial Title: Rheumatoid Arthritis Satisfaction Outcome Research

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Patients aged 19 years or older~2. Patients diagnosed with RA~3. Treatment groups:~1) Tofacitinib citrate users: Patients currently on treatment with tofacitinib citrate in RA therapy for 6 months or more 2) Adalimumab users: Patients currently on treatment with adalimumab in the RA therapy for 6 months or more 4. Reading and writing with enough proficiency to complete assessment instruments in Korean~Exclusion Criteria:~1. Patients currently on tofacitinib citrate or adalimumab for 2 year or more~2. Patients taking Azathioprine and cyclosporine~3. Patients participating in other drug interventional study~4. Patients who have been treated with bDMARDs except Rheumatoid arthritis.

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- tofacitinib citrate users (Type: None): patients who have been using tofacitinib citrate for 6 months or more and less than 2 year in RA patients
- adalimumab users (Type: None): patients who have been using adalimumab for 6 months or more and less than 2 year in RA patients

Based on this trial design, predict the completion outcome and termination type (if applicable).